(Q40213967)

18 September 2017

title

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion (English)

1 reference

18 September 2017

0 references

1 reference

David Zagzag

1

1 reference

18 September 2017

Yevgeniy Lukyanov

2

1 reference

18 September 2017

Li Lan

3

1 reference

18 September 2017

M Aktar Ali

4

1 reference

18 September 2017

Mine Esencay

5

1 reference

18 September 2017

Olga Mendez

6

1 reference

18 September 2017

Herman Yee

7

1 reference

18 September 2017

Evelyn B Voura

8

1 reference

18 September 2017

Elizabeth W Newcomb

9

1 reference

18 September 2017

publication date

30 October 2006

1 reference

18 September 2017

published in

Laboratory Investigation

1 reference

18 September 2017

volume

86

1 reference

18 September 2017

issue

12

1 reference

18 September 2017

page(s)

1221-1232

1 reference

The hypoxic response: huffing and HIFing

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

HIF-1 as a target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Exploiting tumour hypoxia in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

New anticancer strategies targeting HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Kidney cancer: identification of novel targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

CXC chemokine receptor 4 expression and function in human astroglioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

CXCR4 expression mediates glioma cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Regulation of the chemokine receptor CXCR4 by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Blockade of the Stromal Cell–Derived Factor-1/CXCR4 Axis AttenuatesIn vivoTumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor–Independent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

Angiogenesis in gliomas: biology and molecular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Expression of hypoxia-inducible factor 1? in brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Germline mutation profile of theVHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

Chemokine receptor CXCR4 expression in endothelium

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

The use of suppression subtractive hybridization for the study of SDF-1α induced gene-expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

CXC chemokines in angiogenesis of cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700482

7 January 2021

10.1038/LABINVEST.3700482

Identifiers

DOI

1 reference

18 September 2017

1 reference